Screening of T Cell-Related Long Noncoding RNA-MicroRNA-mRNA Regulatory Networks in Non-Small-Cell Lung Cancer

Background. Lung cancer (LC) has the highest mortality rate among all the other types of cancer in the world. T cells are known to be the key factor in inducing the immune response during LC. Objective. In this study, we aimed to screen and analyze RNAs associated with CD8(+) T cells and activated m...

Full description

Bibliographic Details
Main Authors: Jinlong Duan, Yuefen Pan, Xi Yang, Liping Zhong, Yin Jin, Jiamin Xu, Jing Zhuang, Shuwen Han
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2020/5816763
id doaj-a1c2f336ea4748f4ac2a044d4af0e944
record_format Article
spelling doaj-a1c2f336ea4748f4ac2a044d4af0e9442020-11-30T09:11:21ZengHindawi LimitedBioMed Research International2314-61332314-61412020-01-01202010.1155/2020/58167635816763Screening of T Cell-Related Long Noncoding RNA-MicroRNA-mRNA Regulatory Networks in Non-Small-Cell Lung CancerJinlong Duan0Yuefen Pan1Xi Yang2Liping Zhong3Yin Jin4Jiamin Xu5Jing Zhuang6Shuwen Han7Department of Oncology, Huzhou Hospital of Traditional Chinese Medicine, No. 315 South Street, Huzhou, Zhejiang Province, 313000, ChinaDepartment of Oncology, Huzhou Central Hospital, Affiliated Central Hospital Huzhou University, No. 1558, Sanhuan North Road, Wuxing District, Huzhou, Zhejiang Province, 313000, ChinaDepartment of Oncology, Huzhou Central Hospital, Affiliated Central Hospital Huzhou University, No. 1558, Sanhuan North Road, Wuxing District, Huzhou, Zhejiang Province, 313000, ChinaDepartment of Oncology, Huzhou Central Hospital, Affiliated Central Hospital Huzhou University, No. 1558, Sanhuan North Road, Wuxing District, Huzhou, Zhejiang Province, 313000, ChinaDepartment of Laboratory Medicine, Huzhou Central Hospital, Affiliated Central Hospital Huzhou University, No. 1558, Sanhuan North Road, Wuxing District, Huzhou, Zhejiang Province, 313000, ChinaGraduate School of Nursing, Huzhou University, Huzhou, Zhejiang, No. 1 Bachelor Road, Huzhou, Zhejiang Province, 313000, ChinaGraduate School of Nursing, Huzhou University, Huzhou, Zhejiang, No. 1 Bachelor Road, Huzhou, Zhejiang Province, 313000, ChinaDepartment of Oncology, Huzhou Central Hospital, Affiliated Central Hospital Huzhou University, No. 1558, Sanhuan North Road, Wuxing District, Huzhou, Zhejiang Province, 313000, ChinaBackground. Lung cancer (LC) has the highest mortality rate among all the other types of cancer in the world. T cells are known to be the key factor in inducing the immune response during LC. Objective. In this study, we aimed to screen and analyze RNAs associated with CD8(+) T cells and activated memory CD4(+) T cells in lung adenocarcinomas, a subtype of non-small-cell lung cancer (NSCLC-LUAD). Methods. Gene expression RNA-seq data and clinical data of NSCLC-LUAD were downloaded from the XENA database. The data were divided into low scores and high scores based on the Stromal and Immune scores. Then, all the genes were screened for identifying those specifically associated with CD8(+) T cells and activated memory CD4(+) T cells. The screened genes were used for the construction of the protein-protein interaction (PPI) network and for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis along with prognosis analysis. Based on the results of the prognostic analysis, the prognostic-related genes were used to analyze long noncoding (lnc)RNA-micro(mi)RNA-mRNA networks and to predict small chemical molecules. Results. According to the Immune and Stromal scores, a total of 885 upregulated and 29 downregulated RNAs were identified. A total of 90 differentially expressed genes (DEGs) were found to be related to CD8(+) T immune cells, and 48 DEGs were related to activated memory CD4(+) T cells. GPR174 and CD226 suggested a favorable prognosis. For CD8(+) and activated memory CD4(+) T cells, 112 and 113 PPI edges were obtained, respectively. GPR174 was found to be regulated by hsa-miR-19b-5p and hsa-miR-19b-2-5p, and both of these two miRNAs were regulated by lncRNA PCED1B-AS1. CD226 was regulated by hsa-miR-379-5p, which was in turn regulated by lncRNA RP11-81H14.2. Conclusion. Our findings provide a deeper understanding of the T cell-related ceRNA regulatory mechanism in NSCLC-LUAD pathogenesis.http://dx.doi.org/10.1155/2020/5816763
collection DOAJ
language English
format Article
sources DOAJ
author Jinlong Duan
Yuefen Pan
Xi Yang
Liping Zhong
Yin Jin
Jiamin Xu
Jing Zhuang
Shuwen Han
spellingShingle Jinlong Duan
Yuefen Pan
Xi Yang
Liping Zhong
Yin Jin
Jiamin Xu
Jing Zhuang
Shuwen Han
Screening of T Cell-Related Long Noncoding RNA-MicroRNA-mRNA Regulatory Networks in Non-Small-Cell Lung Cancer
BioMed Research International
author_facet Jinlong Duan
Yuefen Pan
Xi Yang
Liping Zhong
Yin Jin
Jiamin Xu
Jing Zhuang
Shuwen Han
author_sort Jinlong Duan
title Screening of T Cell-Related Long Noncoding RNA-MicroRNA-mRNA Regulatory Networks in Non-Small-Cell Lung Cancer
title_short Screening of T Cell-Related Long Noncoding RNA-MicroRNA-mRNA Regulatory Networks in Non-Small-Cell Lung Cancer
title_full Screening of T Cell-Related Long Noncoding RNA-MicroRNA-mRNA Regulatory Networks in Non-Small-Cell Lung Cancer
title_fullStr Screening of T Cell-Related Long Noncoding RNA-MicroRNA-mRNA Regulatory Networks in Non-Small-Cell Lung Cancer
title_full_unstemmed Screening of T Cell-Related Long Noncoding RNA-MicroRNA-mRNA Regulatory Networks in Non-Small-Cell Lung Cancer
title_sort screening of t cell-related long noncoding rna-microrna-mrna regulatory networks in non-small-cell lung cancer
publisher Hindawi Limited
series BioMed Research International
issn 2314-6133
2314-6141
publishDate 2020-01-01
description Background. Lung cancer (LC) has the highest mortality rate among all the other types of cancer in the world. T cells are known to be the key factor in inducing the immune response during LC. Objective. In this study, we aimed to screen and analyze RNAs associated with CD8(+) T cells and activated memory CD4(+) T cells in lung adenocarcinomas, a subtype of non-small-cell lung cancer (NSCLC-LUAD). Methods. Gene expression RNA-seq data and clinical data of NSCLC-LUAD were downloaded from the XENA database. The data were divided into low scores and high scores based on the Stromal and Immune scores. Then, all the genes were screened for identifying those specifically associated with CD8(+) T cells and activated memory CD4(+) T cells. The screened genes were used for the construction of the protein-protein interaction (PPI) network and for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis along with prognosis analysis. Based on the results of the prognostic analysis, the prognostic-related genes were used to analyze long noncoding (lnc)RNA-micro(mi)RNA-mRNA networks and to predict small chemical molecules. Results. According to the Immune and Stromal scores, a total of 885 upregulated and 29 downregulated RNAs were identified. A total of 90 differentially expressed genes (DEGs) were found to be related to CD8(+) T immune cells, and 48 DEGs were related to activated memory CD4(+) T cells. GPR174 and CD226 suggested a favorable prognosis. For CD8(+) and activated memory CD4(+) T cells, 112 and 113 PPI edges were obtained, respectively. GPR174 was found to be regulated by hsa-miR-19b-5p and hsa-miR-19b-2-5p, and both of these two miRNAs were regulated by lncRNA PCED1B-AS1. CD226 was regulated by hsa-miR-379-5p, which was in turn regulated by lncRNA RP11-81H14.2. Conclusion. Our findings provide a deeper understanding of the T cell-related ceRNA regulatory mechanism in NSCLC-LUAD pathogenesis.
url http://dx.doi.org/10.1155/2020/5816763
work_keys_str_mv AT jinlongduan screeningoftcellrelatedlongnoncodingrnamicrornamrnaregulatorynetworksinnonsmallcelllungcancer
AT yuefenpan screeningoftcellrelatedlongnoncodingrnamicrornamrnaregulatorynetworksinnonsmallcelllungcancer
AT xiyang screeningoftcellrelatedlongnoncodingrnamicrornamrnaregulatorynetworksinnonsmallcelllungcancer
AT lipingzhong screeningoftcellrelatedlongnoncodingrnamicrornamrnaregulatorynetworksinnonsmallcelllungcancer
AT yinjin screeningoftcellrelatedlongnoncodingrnamicrornamrnaregulatorynetworksinnonsmallcelllungcancer
AT jiaminxu screeningoftcellrelatedlongnoncodingrnamicrornamrnaregulatorynetworksinnonsmallcelllungcancer
AT jingzhuang screeningoftcellrelatedlongnoncodingrnamicrornamrnaregulatorynetworksinnonsmallcelllungcancer
AT shuwenhan screeningoftcellrelatedlongnoncodingrnamicrornamrnaregulatorynetworksinnonsmallcelllungcancer
_version_ 1715028076361940992